The Role of PET Imaging in Gynecologic Radiation Oncology.
The goal of this review is to discuss the current utility of fluorine-18-fluorodeoxyglucose (FDG)-PET for radiation oncologists who treat gynecologic malignancies. FDG-PET/computed tomography (CT) is recommended for baseline assessment in cervical cancer and for staging in vulvar and vaginal cancer. The authors use FDG-PET/CT in definitive radiation treatment planning for cervical, vulvar, and vaginal cancer. PET may be helpful for salvage radiation treatment planning for any recurrent gynecologic malignancy. There are published data to support the use of PET in posttreatment evaluation of cervical and vulvar cancer.
['Rao|Yuan James|YJ|', 'Grigsby|Perry W|PW|']
D000368:Aged D000369:Aged, 80 and over D005260:Female D019788:Fluorodeoxyglucose F18 D005833:Genital Neoplasms, Female D006801:Humans D008875:Middle Aged D010051:Ovarian Neoplasms D000072078:Positron Emission Tomography Computed Tomography D049268:Positron-Emission Tomography D018787:Radiation Oncology D011856:Radiographic Image Enhancement D012680:Sensitivity and Specificity D002583:Uterine Cervical Neoplasms D014594:Uterine Neoplasms D014846:Vulvar Neoplasms
PET Cervical cancer Vulvar cancer Gynecologic oncology Ovarian cancer Radiation therapy Uterine cancer